MedTech

UNDAE Science – Redefining Sleep Medicine

Sleep is the foundation of health, yet billions suffer from sleep disorders in a field that has seen little innovation for over 100 years and is marked by high rates of misdiagnosis. UNDAE is building the intelligence layer of sleep medicine. The mission: make health an affordable right for all by eliminating sleep disorder misdiagnosis and preventing the chronic diseases that follow. Backed by CHF 1.2M in non-dilutive pre-seed funding and CHF 750k already secured from experienced investors in its CHF 1.1M Seed round, the company is now completing industrialization.

Pre-sale
70%
of CHF 1.1 M reached
maximum 118% - CHF 1.3 M
0
100%
118%
until the
official launch
7
investors

Investors

What our investors say

  • George Masson
    George Masson
    International Medical Technology Distributor & Business Angel
    Noctae technology has the potential to significantly simplify sleep studies, which are currently complex and costly.
  • Renaud Langel
    Renaud Langel
    Co-Founder CENAS Sleep Center, Entrepreneur & Business Angel
    What convinced me to invest early was not only the strength of the science and the proof of concept already achieved, but the quality of the team behind it.
  • Richard Evrard
    Richard Evrard
    CFO and Investor
    As CFO and investor, I invested my own capital because I strongly believe in UNDAE's team, technology and long-term vision.